In Brief: Torrent buys Elder, studies supporting claims must be relevant, common ingredient names on labels, enzyme supplement guidance
This article was originally published in The Tan Sheet
Torrent buys Elder; studies supporting claims must match dose, form – NAD; labels must carry common ingredient names; street drug alternative claims; CRN, ETA publish enzyme guidance; EMA prioritizes 2014 work program; and natural personal care market nears $30 billion.
You may also be interested in...
Evolution Nutraceuticals will discontinue claims that Cardio Miracle prevents or reverses the risk of heart attack and stroke because the investigative unit of the Council of Better Business Bureaus determined is evidence was the known benefits of ingredients in the product rather than studies on the formula. Studies the firm offered looked at the role of ingredients arginine, citrulline and beet powder and other nitrate-rich vegetables in stimulating nitric oxide production within the body, not at whether they helped prevent heart attack and stroke.
The Trump administration says a COVID-19 vaccine could be available in as little as 12 months, but most experts think that is overpromising unless safety or efficacy standards are sacrificed. Many are urging pivotal studies that look at clinical outcomes, not surrogates, for US FDA approval.
When asked about an inspector general report that found hospitals are struggling with tests and resources, and are looking to the federal government to help facilitate more efficient distribution of medical devices to fight the COVID-19 crisis, President Trump attacked the report as a political hit from an Obama holdover.